Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

BridgeBio Pharma (BBIO) Return on Equity: 2019-2025

Historic Return on Equity for BridgeBio Pharma (BBIO) over the last 6 years, with Sep 2025 value amounting to 0.41%.

  • BridgeBio Pharma's Return on Equity rose 5.00% to 0.41% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.41%, marking a year-over-year increase of 5.00%. This contributed to the annual value of 0.39% for FY2024, which is 12.00% down from last year.
  • According to the latest figures from Q3 2025, BridgeBio Pharma's Return on Equity is 0.41%, which was down 5.08% from 0.43% recorded in Q2 2025.
  • Over the past 5 years, BridgeBio Pharma's Return on Equity peaked at 4.09% during Q1 2021, and registered a low of 0.36% during Q3 2024.
  • Its 3-year average for Return on Equity is 0.43%, with a median of 0.43% in 2025.
  • Per our database at Business Quant, BridgeBio Pharma's Return on Equity surged by 476bps in 2021 and then slumped by 342bps in 2022.
  • Quarterly analysis of 5 years shows BridgeBio Pharma's Return on Equity stood at 0.78% in 2021, then declined by 28bps to 0.49% in 2022, then climbed by 3bps to 0.53% in 2023, then dropped by 16bps to 0.36% in 2024, then grew by 5bps to 0.41% in 2025.
  • Its last three reported values are 0.41% in Q3 2025, 0.43% for Q2 2025, and 0.39% during Q1 2025.